RECRUITING

Gait Adaptation and Biofeedback for Cerebral Palsy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research aims to evaluate walking function in children with cerebral palsy (CP). The researchers want to understand how children with CP adapt and learn new ways of moving. They have previously found that measuring how a person controls their muscles is important for assessing walking ability and response to interventions. In these studies, they will adjust the treadmill belt speeds and/or provide real-time feedback to evaluate how a child can alter their movement. The feedback will include a wearable exoskeleton that provides resistance to the ankle and audio and visual cues based on sensors that record muscle activity. This research will investigate three goals: first, to measure how children with CP adapt their walking; second, to see if either repeated training or orthopedic surgery can improve adaptation rates; and third, to determine if individual differences in adaptation relate to improvements in walking function after treatment. This research will help develop better treatments to enhance walking capacity and performance for children with CP.

Official Title

Quantifying Patient-specific Changes in Neuromuscular Control in Cerebral Palsy: Adaptation and Biofeedback During Gait

Quick Facts

Study Start:2023-11-28
Study Completion:2029-01-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05899153

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:7 Years to 18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of bilateral cerebral palsy that impacts both legs
  2. * Gross Motor Functional Classification System Level II
  3. * No surgery or lower-extremity injuries 12 months prior to enrollment
  4. * No botulinum toxin injections in prior 3 months
  5. * No prior selective dorsal rhizotomy surgery
  6. * No history of seizures or cardiac conditions that would preclude walking on a treadmill for 20 minutes
  7. * No current pain that hinders walking
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Katherine M Steele, PhD
CONTACT
206-685-2390
kmsteele@uw.edu
Alyssa Spomer, PhD
CONTACT
AlyssaMSpomer@gillettechildrens.com

Principal Investigator

Katherine M Steele, PhD
PRINCIPAL_INVESTIGATOR
University of Washington

Study Locations (Sites)

Gillette Children's
Saint Paul, Minnesota, 55101
United States

Collaborators and Investigators

Sponsor: University of Washington

  • Katherine M Steele, PhD, PRINCIPAL_INVESTIGATOR, University of Washington

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-28
Study Completion Date2029-01-01

Study Record Updates

Study Start Date2023-11-28
Study Completion Date2029-01-01

Terms related to this study

Keywords Provided by Researchers

  • Gait
  • Rehabilitation

Additional Relevant MeSH Terms

  • Cerebral Palsy